Company Description
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.
It offers synthetic genes and gene fragments, including clonal and non-clonal genes; oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on drug discovery and development.
The company also provides NGS tools, such as library preparation kits, human exome kits, fixed and custom panels, and alliance panels; and positive synthetic controls that provide quality control measures for assay development and routine testing of samples with NGS and reverse transcription polymerase chain reaction assays.
In addition, it offers biopharma services comprising in vivo, in vitro, and in silico antibody discovery services, as well as library generation, screening, developability assays, and antibody expression and characterization.
The company was incorporated in 2013 and is headquartered in South San Francisco, California.
| Country | United States |
| Founded | 2013 |
| IPO Date | Oct 31, 2018 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 923 |
| CEO | Emily Leproust |
Contact Details
Address: 681 Gateway Boulevard South San Francisco, California 94080 United States | |
| Phone | 800 719 0671 |
| Website | twistbioscience.com |
Stock Details
| Ticker Symbol | TWST |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001581280 |
| CUSIP Number | 90184D100 |
| ISIN Number | US90184D1000 |
| Employer ID | 46-2058888 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Emily Marine Leproust Ph.D. | Co-Founder, Board Chair and Chief Executive Officer |
| Dr. Patrick John Finn Ph.D. | President and Chief Operating Officer |
| Adam Laponis | Chief Financial Officer |
| Dennis Cho J.D. | Senior Vice President, Chief Legal Officer and Corporate Secretary |
| Paula Green | Senior Vice President of Human Resources |
| Robert F. Werner | Vice President and Chief Accounting Officer |
| Siyuan Chen | Chief Technology Officer |
| Dr. Michael Fero Ph.D. | Chief Information Officer |
| Nicole Moreno | Senior Vice President of Sales and Support |
| Angela Bitting | Chief Corporate Responsibility Officer and Senior Vice President of Corporate Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 18, 2025 | 144 | Filing |
| Nov 17, 2025 | 10-K | Annual Report |
| Nov 14, 2025 | SCHEDULE 13G | Filing |
| Nov 14, 2025 | 8-K | Current Report |
| Nov 10, 2025 | SCHEDULE 13G | Filing |
| Nov 3, 2025 | 144 | Filing |
| Nov 3, 2025 | 144 | Filing |
| Nov 3, 2025 | 144 | Filing |
| Nov 3, 2025 | 144 | Filing |
| Nov 3, 2025 | 144 | Filing |